Covaxin Phase III trial from November
Vaccine maker Bharat Biotech’s decision follows DCGI nod
Full Article
Covaxin Phase III trial from November
Hindu
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..
-
NA Proactive news snapshot: American Resources, MagicMed Industries, AIM ImmunoTech, Water Tower Research, Genprex UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Algernon Pharmaceuticals, Loop Insights, Esports Entertainment, BioSig Technologies …
Proactive Investors
-
Amryt Pharma shares additional encouraging data from successful phase III trial of gel for rare skin disease
Proactive Investors
-
States urged to adopt national approach: Niti Aayog on 'free vaccine'
Mid-Day
Advertisement
More coverage
Long Road Ahead To COVID-19 Immunity Even With Vaccines – OpEd
Eurasia Review
By Prabir Purkayastha*
As the pandemic continues to spread throughout the world, many countries seem to have given up..